The recall of Auvi-Q has been as big a shock to allergists as it has been to patients. I have been giving new patients demonstrations of both Auvi-Q and EpiPen for a couple of years and EVERYONE prefers Auvi-Q. So I am following the recall closely. I wish I had better news, but this is the latest we have had at the office:
Auvi-Q should ONLY be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK OR INTRAVENOUSLY.
- To report an adverse event to Sanofi US by phone at 1-800-633-1610, Option 2 or by fax at1-908-203- 7783.
- To report an adverse event to the FDA Med Watch Program by fax 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787 or on the MedWatch website at www.fda.gov/medwatch/report.
55 Corporate Drive
Bridgewater, New Jersey 08807